Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Chemomab Therapeutics Ltd DRC
2QV0Current price
1.31 EUR
-0.04 EUR (-2.96%)
Last closed
1.48 USD
Company
www.chemomab.com
ISIN
US16385C1045
Sector
Healthcare
Industry
Biotechnology
Exchange
Frankfurt Exchange
Capitalization
26 022 108 USD
Yield for 12 month
+145.00 %
1Y
3Y
5Y
10Y
15Y
2QV0
Chemomab Therapeutics Ltd., a clinical-stage biotechnology company, discovers and develops therapeutics for the treatment of fibrotic and inflammatory diseases in the United States. Its lead product candidate is CM-101, a humanized monoclonal antibody attenuates the basic function of CCL24 that is in phase 2 clinical trial for the treatment of primary sclerosing cholangitis (PSC) and systemic sclerosis (SSc). Chemomab Therapeutics Ltd. was founded in 2011 and is based in Tel Aviv, Israel. Address: Building 7, Tel Aviv, Israel, 6158002
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
8.67 USDP/E ratio
–Dividend Yield
–Current Year
–
Last Year
–
Current Quarter
–
Last Quarter
–
Current Year
-66 827 USD
Last Year
-57 773 USD
Current Quarter
-26 901 USD
Last Quarter
–
Key Figures 2QV0
1 year
3 years
5 years
10 years
EBITDA
-15 969 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-46.18 %
PEG Ratio
–
Return On Equity TTM
-93.8 %
Wall Street Target Price
8.67 USD
Revenue TTM
–
Book Value
0.7 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
–
Earnings per share
-1.06 USD
Diluted Eps TTM
-1.06 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics 2QV0
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History 2QV0
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:16
Payout Ratio
–
Last Split Date
17.03.2021
Dividend Date
–
Stock Valuation 2QV0
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
13.0039
Enterprise Value Revenue
–
Price Sales TTM
–
Enterprise Value EBITDA
0.3331
Price Book MRQ
2.6061
Financials 2QV0
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators 2QV0
For 52 weeks
0.42 USD
2.55 USD
50 Day MA
1.63 USD
Shares Short Prior Month
72 487
200 Day MA
1.05 USD
Short Ratio
0.59
Shares Short
93 591
Short Percent
0.5 %
BeatStart